CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01653717 · COMPLETED
Trial details
- NCT number
- NCT01653717
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-11
- Primary completion
- 2017-08-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.